Cargando…
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
BACKGROUND: Mantle cell lymphoma (MCL) is a distinct clinical pathologic subtype of B cell non-Hodgkin’s lymphoma often associated with poor prognosis. New therapeutic approaches based on boosting anti-tumor immunity are needed. MCL is associated with overexpression of cyclin D1 thus rendering this...
Autores principales: | Chen, Jingtao, Zurawski, Gerard, Zurawski, Sandy, Wang, Zhiqing, Akagawa, Keiko, Oh, Sangkon, Hideki, Ueno, Fay, Joseph, Banchereau, Jacques, Song, Wenru, Palucka, A Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424584/ https://www.ncbi.nlm.nih.gov/pubmed/25888530 http://dx.doi.org/10.1186/s13045-015-0131-7 |
Ejemplares similares
-
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4(+) T cells
por: Li, Dapeng, et al.
Publicado: (2012) -
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells
por: Yin, Wenjie, et al.
Publicado: (2016) -
Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells
por: Martirosyan, Anna, et al.
Publicado: (2012) -
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009) -
Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8(+ )T cells by dendritic cells loaded with killed allogeneic breast cancer cells
por: Saito, Hiroaki, et al.
Publicado: (2006)